Finjan Provides Litigation Update in Blue Coat Case
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Finjan Holdings (FNJN) Updates on Blue Coat Systems Litigation; Pre-Trial Conference Completed
July 14, 2015 7:33 AM EDTFinjan Holdings (NASDAQ: FNJN) is providing a litigation update in its case against Blue Coat Systems, Inc. (CAND-13-cv-03999-BLF). Pre-trial conference was completed July 2, 2015 and the case will proceed to trial, as planned July 20, 2015, with all six patents against accused infringing Blue Coat products and services. The trial is expected to last for two weeks.
A Pre-trial conference... More
